|COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring.|
Engineering and medicine: Opportunities in type 1 diabetes
If you have a question about this talk, please contact Dr Jason Z JIANG.
The development of the artificial pancreas is underway with considerable stakeholders input and industry interest. Aimed to treat type 1 diabetes of all ages from early childhood to maturity, the artificial pancreas consists of a continuous glucose meter, control algorithm and an insulin pump. Significant life sciences opportunities exist to complement the clinical work and accelerate research progress and commercialisation of the artificial pancreas.
This talk is part of the CUED Control Group Seminars series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
Other listsHistory and the Law Reading and Reception Studies Seminar CU Kazakh Society
Other talksImaging phatocytosis: receptors, phospholipids and the cytoskeleton Host: Rob Kay (MRC-LMB) INTERROGATING THE ARCHITECTURE OF CANCER GENOMES Public Perception Towards Nuclear Risk in the UK: Implications For Nuclear Safety Emergency Governance (with David Reiner) DB Schenker Exoplanet Journal Club Prevention is Better than Cure: closing lecture by the Vice Chancellor